Literature DB >> 3119155

Two distinct effects of 5-hydroxytryptamine on single cortical neurons.

M F Davies1, R A Deisz, D A Prince, S J Peroutka.   

Abstract

The ability of the indoleamine serotonin (5-hydroxytryptamine; 5-HT) to alter membrane characteristics of neocortical neurons was analyzed using intracellular recording techniques. The present study demonstrates that 5-HT primarily depolarized 68% of cortical neurons probably by decreasing a resting K+ conductance, an effect blocked by the antagonists ritanserin and cinanserin and apparently mediated by 5-HT2 receptors. A hyperpolarization associated with an increased conductance state and insensitive to 5-HT2 antagonists was observed in 26% of the neurons and could be mimicked by the selective 5-HT1A agonist (+/-)-8-hydroxy-2-(di-N-propyl-amino)tetralin (8-OH-DPAT). Therefore cortical pyramidal neurons contain at least two distinct functional 5-HT receptors whose activation produces opposing effects on membrane potential and conductance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119155     DOI: 10.1016/0006-8993(87)90861-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

Review 1.  Serotonin and prefrontal cortex function: neurons, networks, and circuits.

Authors:  M Victoria Puig; Allan T Gulledge
Journal:  Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.590

2.  Serotonergic modulation of supragranular neurons in rat sensorimotor cortex.

Authors:  R C Foehring; J F M van Brederode; G A Kinney; W J Spain
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  Inhibition by 5-HT of the synaptic responses evoked by callosal fibers on cortical neurons in the mouse.

Authors:  José A Troca-Marín; Emilio Geijo-Barrientos
Journal:  Pflugers Arch       Date:  2010-09-14       Impact factor: 3.657

4.  5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones.

Authors:  R A North; N Uchimura
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

Review 5.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

6.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

7.  Convergence and divergence of neurotransmitter action in human cerebral cortex.

Authors:  D A McCormick; A Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.

Authors:  D M Bowen; A Najlerahim; A W Procter; P T Francis; E Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Action of 5-hydroxytryptamine in facilitating N-methyl-D-aspartate depolarization of cortical neurones mimicked by calcimycin, cyclopiazonic acid and thapsigargin.

Authors:  S Rahman; R S Neuman
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

10.  Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.

Authors:  J Ulrichsen; J S Partilla; E M Dax
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.